Joseph P Marino, Jr

Title: Joseph P Marino, Jr: Innovator in sEH Inhibitors

Introduction

Joseph P Marino, Jr. is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sEH inhibitors. With a total of 7 patents to his name, Marino's work has the potential to impact the treatment of various diseases.

Latest Patents

Marino's latest patents focus on novel sEH inhibitors and their applications in treating diseases mediated by the sEH enzyme. One of his inventions is directed to a specific compound, (Cis)-N-{[4-cyano-2-(trifluoromethyl)phenyl]methyl}-3-{[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino}cyclohexanecarboxamide, or its pharmaceutically acceptable salt. Another patent involves compounds according to a defined formula, which can be used in treating conditions such as hypertension. These inventions also encompass pharmaceutical compositions and methods for inhibiting sEH.

Career Highlights

Throughout his career, Marino has worked with prominent companies in the pharmaceutical industry, including GlaxoSmithKline LLC and SmithKline Beecham Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Marino has collaborated with talented individuals in his field, including Yun Ding and Reema K Thalji. These partnerships have likely enhanced his research and development efforts.

Conclusion

Joseph P Marino, Jr. is a distinguished inventor whose work on sEH inhibitors holds promise for advancing medical treatments. His contributions to the pharmaceutical industry reflect his dedication to innovation and improving health outcomes.